FGF-23 in dialysis patients: Ready for prime time?

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1078-1081

  Zoccali, Carmine ^a,b  

^a CNR   (Italy)

^b Presso Euroline   (Italy)

Author keywords

CKD; Dialysis; ESRD; FGF 23; Survival

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

CLINICAL PRACTICE; DEATH; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; MORTALITY; NONHUMAN; NOTE; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN FUNCTION;

FIBROBLAST GROWTH FACTORS; HUMANS; KIDNEY FAILURE, CHRONIC; PHOSPHATES; RENAL DIALYSIS;

EID: 65349099604     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn688     Document Type: Note

References (8)

1. Danziger J. The bone-renal axis in early chronic kidney disease: an emerging paradigm. Nephrol Dial Transplant 2008; 23: 2733-2737
2. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
3. Silve C, Beck L. Is FGF23 the long sought after phosphaturic factor phosphatonin? Nephrol Dial Transplant 2002; 17: 958- 961
4. Du L, Desbarats M, Viel J et al. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 1996; 36: 22-28
5. Sitara D, Kim S, Razzaque MS et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet2008; 4: e1000154
6. Tripepi G, Jager KJ, Dekker FW et al. Testing for causality and prognosis: etiological and prognostic models. Kidney Int 2008; 74: 1512- 1515
7. Martin MM, Lee EJ, Buckenberger JA et al. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006; 281: 18277-18284
8. Zoccali C, Testa A, Spoto B et al. Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis 2006; 47: 332-341